Progyny (PGNY) Receivables - Other (2018 - 2026)

Progyny (PGNY) has reported Receivables - Other for 9 consecutive years, with $36.4 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Receivables - Other fell 26.02% year-over-year to $36.4 million in Q2 2026; TTM through Jun 2026 was $36.4 million, a 26.02% decrease from a year earlier, with the FY2025 full-year figure at $33.9 million, down 27.87% from the prior year.
• Receivables - Other was $36.4 million for Q2 2026 at Progyny, up from $35.4 million in the prior quarter.
• Over five years, Receivables - Other peaked at $76.5 million in Q2 2024 and troughed at $31.3 million in Q1 2022.
• A 5-year average of $48.4 million and a median of $46.2 million in 2023 frame the typical range for Receivables - Other.
• Across the five-year window, Receivables - Other soared 164.92% in 2022 and tumbled 39.38% in 2026, its largest moves.
• Over 5 years, Receivables - Other stood at $42.9 million in 2022, then gained by 5.13% to $45.1 million in 2023, then gained by 4.21% to $47.0 million in 2024, then decreased by 27.87% to $33.9 million in 2025, then rose by 7.37% to $36.4 million in 2026.
• The last three Receivables - Other figures came in at $36.4 million (Q2 2026), $35.4 million (Q1 2026), and $33.9 million (Q4 2025), per Business Quant data.